Here are five notes:
1. The shareholder sold 467,293 shares of the stock.
2. Each share sold at an average price of $22.60.
3. K2M, a global medical device company, presently has a consensus rating of “Buy” and a price target of $28.75.
4. K2M shares have a 50-day moving average of $24.27 and a 200-day moving average of $22.29.
5. The company’s market cap is approximately $958 million.
More on devices:
Stryker moves to dismisses lawsuit involving Accolade hip replacement system — 4 quick facts
Bone grafts market growing globally: 5 things to know
4 notes on new FDA-approved prosthesis for amputations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
